When cell and gene therapy manufacturing often continues at risk, they are highly vulnerable to contamination. Testing for bacterial endotoxins frequently is both advantageous and critical, especially when using a test method which can tolerate small volume samples, reduce the chance for human error, and maximize assay efficiency. 

Watch the highlighted webinars to learn how two customers, the Royal Prince Alfred Hospital in Australia, and the Fondazione RiMED - IRCCS-ISMETT Hospital in Italy, utilized the Endosafe^® FDA-licensed LAL cartridge technology via the PTS™ systems in their labs to obtain real-time, quantitative endotoxin results in 15 minutes.